KIAA1549 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.148600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.512200E-02
Normal-vs-Stage2
1.899020E-01
Normal-vs-Stage3
4.580600E-01
Normal-vs-Stage4
1.347810E-01
Stage1-vs-Stage2
2.491200E-01
Stage1-vs-Stage3
2.793800E-01
Stage1-vs-Stage4
9.286000E-01
Stage2-vs-Stage3
6.887200E-01
Stage2-vs-Stage4
4.017200E-01
Stage3-vs-Stage4
4.207200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.174800E-01
Normal-vs-AfricanAmerican
3.140000E-01
Normal-vs-Asian
3.449600E-01
Caucasian-vs-AfricanAmerican
9.433000E-01
Caucasian-vs-Asian
5.691000E-01
AfricanAmerican-vs-Asian
7.610000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.352600E-01
Normal-vs-Female
2.007200E-01
Male-vs-Female
4.953000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.391800E-01
Normal-vs-Age(41-60Yrs)
8.116000E-02
Normal-vs-Age(61-80Yrs)
3.003600E-01
Normal-vs-Age(81-100Yrs)
1.294170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.841000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.725800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.571990E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.566800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.482600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.127200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.313400E-01
Normal-vs-Daily Drinker
2.148800E-01
Normal-vs-Weekly Drinker
5.647500E-02
Normal-vs-Occasional Drinker
3.259000E-01
Normal-vs-Social Drinker
1.156970E-01
Non Drinker-vs-Daily Drinker
8.604600E-01
Non Drinker-vs-Weekly Drinker
9.971800E-01
Non Drinker-vs-Occasional Drinker
4.973200E-01
Non Drinker-vs-Social Drinker
2.175600E-01
Daily Drinker-vs-Weekly Drinker
8.608600E-01
Daily Drinker-vs-Occasional Drinker
4.352600E-01
Daily Drinker-vs-Social Drinker
1.715010E-01
Weekly Drinker-vs-Occasional Drinker
4.827600E-01
Weekly Drinker-vs-Social Drinker
2.182000E-01
Occasional Drinker-vs-Social Drinker
8.342000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.693000E-01
Normal-vs-Grade 2
6.164400E-01
Normal-vs-Grade 3
5.422000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.785770E-01
Grade 1-vs-Grade 3
2.692400E-01
Grade 1-vs-Grade 4
5.693000E-01
Grade 2-vs-Grade 3
6.093200E-01
Grade 2-vs-Grade 4
6.164400E-01
Grade 3-vs-Grade 4
5.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.667200E-01
Normal-vs-NonDiabetic
1.980400E-01
Diabetic-vs-NonDiabetic
2.236400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.356020E-01
Normal-vs-NoPancreatitis
2.525600E-01
Pancreatitis-vs-NoPancreatitis
9.344400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.979000E-01
Normal-vs-N1
1.696000E-01
N0-vs-N1
3.829800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.184200E-02
Normal-vs-TP53-NonMutant
2.259400E-01
TP53-Mutant-vs-TP53-NonMutant
8.181200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
